For patients with diabetes and other endocrine or metabolic disorders, therapy options and management approaches for diabetes and endocrinology are more plentiful than ever. Treatment is tailored to the individual, with the type of disease and its severity determining the optimal course of treatment.
Led by Joyce Niland, Ph.D., the Department of Diabetes & Cancer Discovery Science within the Diabetes & Metabolism Research Institute provides leading-edge research to support advances in diabetes, metabolism and oncology research.
The Department of Diabetes Complications & Metabolism is at the forefront of research on the complications of diabetes and was the first to study epigenetic changes in diabetic complications.
The Department of Diabetes Immunology, headed by Bart O. Roep, Ph.D., is dedicated to studying immune system mechanisms and their impact on diabetes development and control — particularly type 1 diabetes.
The Department of Molecular & Cellular Endocrinology, headed by Debbie C. Thurmond, Ph.D., is pioneering efforts to investigate biological mechanisms involved with type 1 and type 2 diabetes development and substances that promote or interfere with those processes.
This department focuses on stem cell biology and development, translational immunology, islet imaging, isolation and distribution, islet quality assessment and new drug discoveries to improve diabetes treatment and management.
Scientists at The Wanek Family Project for Type 1 Diabetes are creating powerful new approaches to treating type 1 diabetes that will move beyond just managing the disease to curing it.